What is Octreotide?

The short answer

Octreotide is a peptide, a short chain of amino acids. In the US, you need a prescription to get Octreotide.

Get updates on Octreotide

What it is

Type
Somatostatin analog (peptide)
Also known as
sandostatin, sandostatin lar, mycapssa, bynfezia

Regulatory status

FDA-approved (Rx) How we label status

As of October 4, 2026, Octreotide is an FDA-approved prescription drug for acromegaly; carcinoid and VIP-secreting tumor symptoms.

See Octreotide in the Index →

Federal (FDA)
Approved Rx (Sandostatin NDA019667, 1988; LAR; oral Mycapssa)
503A compounding
Approved-drug component (not in any 503A category) (as of May 14, 2026)

References

Sources as of October 4, 2026

  1. DailyMed: dailymed.nlm.nih.gov/dailymed/drugInfo.cfm